Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential

Drug Delivery

Volumn 18, Issue 8, 2011, Pages 599-612

  Singh, Bhupinder ^a   Khurana, Lalit ^b   Bandyopadhyay, Shantanu ^a   Kapil, Rishi ^a   Katare, O O P ^a  

^a PANJAB UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Central composite design; Design of experiments; Intestinal perfusion; SEDDS; Self emulsifying

Indexed keywords

CARLOC; CARVEDILOL; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; GENERIC DRUG; LIPID; NANOPARTICLE; OCTANOIN; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; EMULSION; HYDROPHILICITY; IN VITRO STUDY; INTESTINE PERFUSION; LYMPHATIC SYSTEM; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RESPONSE VARIABLE; SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM; TIME; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BIOLOGICAL AVAILABILITY; CAPRYLATES; CARBAZOLES; CARDIOVASCULAR AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; ETHYLENE GLYCOLS; EXCIPIENTS; GLYCERIDES; GLYCEROL; INTESTINAL ABSORPTION; JEJUNUM; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; OILS; PARTICLE SIZE; PERFUSION; PROPANOLAMINES; RATS; RATS, WISTAR; SOLUBILITY;

EID: 82055197168     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2011.604686     Document Type: Article

References (47)

1. Arsenault, W.G., Boothe, D.M., Gordon, S.G., Miller, M.W., Chalkley, J.R., Petrikovics, I. (2005). Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs. American J Vet Res. 66:2172-6.
2. Bogaard, H.J., Natarajan, R., Mizuno, S., Abbate, A., Chang, P.J., Chau, V.Q., Hoke, N.N., Kraskauskas, D., Kasper, M., Salloum, F.N., Voelkel, N.F. (2010). Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. Am J Respir Crit Care Med. 182:652-60.
3. Charman, S.A., Charman, W.N., Rogge, M.C., Wilson, T.D., Dutko, F.J., Pouton, C.W. (1992). Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 9:87-93.
4. Constantinides, P.P., Wasan, K.M. (2007). Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: In vitro/in vivo case studies. J Pharm Sci. 96:235-48. (Pubitemid 46363554)
5. Craig, D.Q.M., Barker, S.A., Banning, D., Booth, S.W. (1995). An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm. 114:103-10. (Pubitemid 24377034)
6. Cui, S.X., Nie, S.F., Li, L., Wang, C.G., Pan, W.S., Sun, J.P. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm. 35:603-11.
7. de Smidt, P.C., Campanero, M.A., Troconiz, I.F. (2004). Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. Int J Pharm. 270:109-18. (Pubitemid 38077092)
8. Elnaggar, Y.S., El-Massik, M.A., Abdallah, O.Y. (2009). Selfnanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm. 380:133-41.
9. Gao, F., Zhang, Z., Bu, H., Huang, Y., Gao, Z., Shen, J., Zhao, C., Li Y. (2011). Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: Performance and mechanism. J Control Release. 149:168-74.
10. Gupta, H., Bhandari, D., Sharma, A. (2009). Recent trends in oral drug delivery: A review. Recent Pat Drug Deliv Formul. 3:162-73.
11. Hauss, D.J. (2007). Oral lipid-based formulations: Enhancing the bioavailability of poorly water-soluble drugs, drugs and the pharmaceutical sciences. 1st ed. Vol 170. New York: Informa Healthcare USA, Inc.
12. Ho, Y.F., Lai, M.Y., Yu, H.Y., Huang, D.K., Hsueh, W.C., Tsai, T.H., Lin, C.C. (2008). Application of rat in situ single-pass intestinal perfusion in the evaluation of presystemic extraction of indinavir under different perfusion rates. J Formos Med Assoc. 107:37-45.
13. Hokama, N., Hobara, N., Kameya, H., Ohshiro, S., Sakanashi, M. (1999). Rapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 732:233-8. (Pubitemid 29421765)
14. http://www.ich.org/cache/compo/363-272-1.html, accessed 12 December 2010.
15. http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/ Quality/Q1A-R2/Step4/Q1A-R2-Guideline.pdf, accessed 25 December 2010.
16. http://www.reportlinker.com/p0189377/Innovations-in-Oral-Solid-Drug- Delivery-Advances-in-nanotechnology-controlledformulations-peptide-delivery. html, accessed 24 December 2010.
17. http://www.who.int/topics/cardiovascular-diseases/en/, accessed 20 December 2010.
18. Humberstone, A.J., Charman, W.N. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev. 25:103-28.
19. Joshi, M., Pathak, S., Sharma, S., Patravale, V. (2008). Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. Int J Pharm. 362:172-8.
20. Koga, K., Kusawake, Y., Ito, Y., Sugioka, N., Shibata, N., Takada, K. (2006). Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate. Eur J Pharm Biopharm. 64:82-91. (Pubitemid 44142241)
21. Kommuru, T.R., Gurley, B., Khan, M.A., Reddy, I.K. (2001). Selfemulsifying drug delivery systems (SEDDS) of coenzyme Q10: Formulation development and bioavailability assessment. Int J Pharm. 212:233-46. (Pubitemid 32119449)
22. Laia, C.A.T., López-Cornejo, P., Costa, S.M.B., dOliveira, J., Martinho, J.M.G. (1998). Dynamic light scattering study of AOT microemulsions with nonaqueous polar additives in an oil continuous phase. Langmuir. 14:3531-7. (Pubitemid 128581285)
23. Morgan, T. (1994). Clinical pharmacokinetics and pharmacodynamics of carvedilol. Clin Pharmacokinet. 26:335-46. (Pubitemid 24148199)
24. Nielsen, F.S., Petersen, K.B., Mürllertz, A. (2008). Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm. 69:553-62.
25. Patel, M., Tekade, A., Gattani, S., Surana, S. (2008). Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS PharmSciTech. 9:1262-9.
26. Porter, C.J., Charman, W.N. (2001). Intestinal lymphatic drug transport: An update. Adv Drug Deliv Rev. 50:61-80. (Pubitemid 32727277)
27. Porter, C.J.H., Trevaskis, N.L., Charman, W.N. (2007). Lipids and lipidbased formulations: Optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 6:231-48. (Pubitemid 46344627)
28. Pouton, C.W., Porter, C.J. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 60:625-37.
29. Sha, X., Yan, G., Wu, Y., Li, J., Fang, X. (2005). Effect of selfmicroemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. Eur J Pharm Sci. 24:477-86. (Pubitemid 40387261)
30. Shafiq-un-Nabi, S., Shakeel, F., Talegaonkar, S., Ali, J., Baboota, S., Ahuja, A., Khar, R.K., Ali, M. (2007). Formulation development and optimization using nanoemulsion technique: A technical note. AAPS PharmSciTech 8:E1-E6
31. Singh, B., Ahuja, N. (2002). Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm. 28:431-42. (Pubitemid 34552236)
32. Singh, B., Bandopadhyay, S., Kapil, R., Singh, R., Katare, O. (2009b). Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 26:427-521.
33. Singh, B., Bandyopadhyay, S., Katare, O.P. (2009a). Book review on Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs". Drug Deliv. 16:125-6.
34. Singh, B., Chakkal, S.K., Ahuja, N. (2006). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech. 7:E3.
35. Singh, B., Dahiya, M., Saharan, V., Ahuja, N. (2005b). Optimizing drug delivery systems using systematic design of experiments." Part II: Retrospect and prospects. Crit Rev Ther Drug Carrier Syst. 22:215-94.
36. Singh, B., Kaur, T., Singh, S. (1997). Correction of raw dissolution data for loss of drug during sampling. Indian J Pharm Sci. 59:196-9. (Pubitemid 27414628)
37. Singh, B., Kumar, R., Ahuja, N. (2005a). Optimizing drug delivery systems using systematic design of experiments." Part I: Fundamental aspects. Crit Rev Ther Drug Carrier Syst. 22:27-105.
38. Singh, B., Singh, S. (1998). A Comprehensive computer program for study of drug release kinetics from compressed matrices. Indian J Pharm Sci. 60:313-6.
39. Spernath, A., Aserin, A. (2006). Microemulsions as carriers for drugs and nutraceuticals. Adv Colloid Interface Sci. 128-130, 47-64. (Pubitemid 46215528)
40. Thi, T.D., Van Speybroeck, M., Barillaro, V., Martens, J., Annaert, P., Augustijns, P., Van Humbeeck, J., Vermant, J., Van den Mooter, G. (2009). Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS. Eur J Pharm Sci. 38:479-88.
41. VCCLAB VCCL. (2005). Available online at: http://www.vcclab.org, accessed 22 December 2010.
42. Vogt, M., Kunath, K., Dressman, J.B. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. Eur J Pharm Biopharm 68:283-8.
43. von Mollendorff, E., Reiff, K., Neugebauer, G. (1987). Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clin Pharmacol. 33:511-3. (Pubitemid 18017553)
44. Wei, L., Sun, P., Nie, S., Pan, W. (2005). Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm. 31:785-94. (Pubitemid 41356195)
45. Wen, H., Jiang, H., Lu, Z., Hu, X., He, B., Tang, Q., Huang, C. (2010). Carvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in rats. Biomed Pharmacother. 64:446-50.
46. Yao, J., Lu, Y., Zhou, J.P. (2008). Preparation of nobiletin in selfmicroemulsifying systems and its intestinal permeability in rats. J Pharm Pharm Sci. 11:22-9.
47. Yavuz, B., Bilensoy, E., Vural, I., Sumnu, M. (2010). Alternative oral exemestane formulation: improved dissolution and permeation. Int J Pharm. 398:137-45.